Federal award
CLEVELAND BIOLABS, INC.
W9113M08C0151
Contract
Obligated and Ceiling
- Obligated (net)
- $8,346,083.78
- Ceiling (potential value, not spending)
- $8,346,083.78
- Current value
- $8,346,083.78
- Gross positive obligations
- $9,148,699.82
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CLEVELAND BIOLABS, INC. · J223MEGF2LP1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CLEVELAND BIOLABS, INC. · J223MEGF2LP1
- Awarding agency
- Department of War · sub-agency 2100 · office W9113M
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- W9113M08C0151
- Award type code
- D
- Actions
- 12 · Mar 31, 2008 to Sep 9, 2010
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 9, 2010 | FY2010 | P00010 | C | −$802,616.04 | — |
| Apr 22, 2010 | FY2010 | P00009 | C | $235,394.32 | — |
| Apr 16, 2010 | FY2010 | P00008 | B | $54,225.00 | — |
| Aug 25, 2009 | FY2009 | P00007 | B | $0.00 | — |
| Jun 12, 2009 | FY2009 | P00006 | G | $2,502,583.00 | — |
| May 20, 2009 | FY2009 | P00005 | B | $54,225.00 | — |
| Mar 19, 2009 | FY2009 | P00004 | C | $734,591.45 | — |
| Feb 24, 2009 | FY2009 | P00003 | C | $1,390,626.55 | — |
| Jul 31, 2008 | FY2008 | PZ0001 | C | $3,136,973.50 | — |
| May 6, 2008 | FY2008 | P00002 | M | $0.00 | — |
| Apr 10, 2008 | FY2008 | P00001 | M | $0.00 | — |
| Mar 31, 2008 | FY2008 | 0 | — | $1,040,081.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.